Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerard Anderson

Showing results (21-30 of 78) with videos related to

Pageof 8
Sort By:
Health Services Research|May 9, 2021
Comparing the value of community benefit and Tax-Exemption in non-profit hospitalsHossein Zare, Matthew D Eisenberg, Gerard Anderson
JAMA Internal Medicine|November 3, 2025
When Academic Medical Centers Invest in Bringing Their Research to MarketAleksandra Drmanovic, So-Yeon Kang, Gerard Anderson
Journal of the American Geriatrics Society|November 2, 2019
Complex Patients and Quality of Care in Medicare AdvantageEva H DuGoff, Cynthia Boyd, Gerard Anderson
The American Journal of Managed Care|May 18, 2021
Variability of COPD inhaler coverage in Medicare Part DBenjamin Wormser, Mariana P Socal, Gerard Anderson
Journal of General Internal Medicine|February 2, 2021
The Association Between Drug Approvals and Burden of Disease From 1990 to 2017Tarun George, Jeromie Ballreich, Antonio Trujillo, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|April 27, 2026
Balancing opportunities and risks of artificial intelligence in drug policy and regulationPineal Bareamichael, Tinglong Dai, Mariana Socal, et al.
Inquiry : a Journal of Medical Care Organization, Provision and Financing|February 14, 2018
Comparing the Value of Nonprofit Hospitals' Tax Exemption to Their Community BenefitsBradley Herring, Darrell Gaskin, Hossein Zare, et al.
Pharmacotherapy|October 22, 2025
Developing New Drugs for the COVID-19 Emergency: Anatomy of the U.S. ResponseThomas J Moore, Mariana P Socal, Gerard Anderson
JAMA|January 10, 2016
Role of the FDA in Affordability of Off-Patent PharmaceuticalsJeremy A Greene, Gerard Anderson, Joshua M Sharfstein
Health Affairs Scholar|November 7, 2024
Medigap-guaranteed issue associated with Medicare Advantage disenrollment for beneficiaries administered a part B drugAngela Liu, David Pittman, Gerard Anderson, et al.
Pageof 8

Showing results (21-30 of 78) with videos related to

Sort By:
Pageof 8
Health Services Research|May 9, 2021
Comparing the value of community benefit and Tax-Exemption in non-profit hospitalsHossein Zare, Matthew D Eisenberg, Gerard Anderson
JAMA Internal Medicine|November 3, 2025
When Academic Medical Centers Invest in Bringing Their Research to MarketAleksandra Drmanovic, So-Yeon Kang, Gerard Anderson
Journal of the American Geriatrics Society|November 2, 2019
Complex Patients and Quality of Care in Medicare AdvantageEva H DuGoff, Cynthia Boyd, Gerard Anderson
The American Journal of Managed Care|May 18, 2021
Variability of COPD inhaler coverage in Medicare Part DBenjamin Wormser, Mariana P Socal, Gerard Anderson
Journal of General Internal Medicine|February 2, 2021
The Association Between Drug Approvals and Burden of Disease From 1990 to 2017Tarun George, Jeromie Ballreich, Antonio Trujillo, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|April 27, 2026
Balancing opportunities and risks of artificial intelligence in drug policy and regulationPineal Bareamichael, Tinglong Dai, Mariana Socal, et al.
Inquiry : a Journal of Medical Care Organization, Provision and Financing|February 14, 2018
Comparing the Value of Nonprofit Hospitals' Tax Exemption to Their Community BenefitsBradley Herring, Darrell Gaskin, Hossein Zare, et al.
Pharmacotherapy|October 22, 2025
Developing New Drugs for the COVID-19 Emergency: Anatomy of the U.S. ResponseThomas J Moore, Mariana P Socal, Gerard Anderson
JAMA|January 10, 2016
Role of the FDA in Affordability of Off-Patent PharmaceuticalsJeremy A Greene, Gerard Anderson, Joshua M Sharfstein
Health Affairs Scholar|November 7, 2024
Medigap-guaranteed issue associated with Medicare Advantage disenrollment for beneficiaries administered a part B drugAngela Liu, David Pittman, Gerard Anderson, et al.
Pageof 8